Summit Therapeutics Inc (NAS:SMMT)
$ 13.66 -1.31 (-8.75%) Market Cap: 10.90 Bil Enterprise Value: 9.93 Bil PE Ratio: 0 PB Ratio: 19.51 GF Score: 27/100

Summit Therapeutics Inc (SMMT) Transcripts

  • 1